Oligonucleotides comprising a nonphosphate backbone linkage

Details for Australian Patent Application No. 2005327517 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Rajeev, Kallanthottathil G.; Manoharan, Muthiah

Agent Griffith Hack

Pub. Number AU-B-2005327517

PCT Pub. Number WO2006/088490

Priority 60/584,061 30.06.04 US; 60/614,528 30.09.04 US

Filing date 29 June 2005

Wipo publication date 24 August 2006

Acceptance publication date 26 May 2011

International Classifications

C07H 19/167 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 19/173 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/088490 Priority application(s): WO2006/088490

26 May 2011 Application Accepted

  Published as AU-B-2005327517

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005327520-Resequencing pathogen microarray

2005327516-Dissolvable films and methods including the same